{"id":"W4296905415","doi":"10.1016/j.eururo.2022.09.003","title":"Predictive Biomarkers in Muscle Invasive Bladder Cancer: Are We There Yet?","year":2022,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Alberta Cancer Foundation; Princess Margaret Cancer Centre","funders":"EMD Serono; Eisai Canada; Astellas Pharma Canada; Janssen Pharmaceuticals; Bayer; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Prostate cancer; Bladder cancer; Cancer; Risk assessment; Prostate; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006593497,0.0007388277,0.002331645,0.000883697,0.002166981,0.003828159,0.001575584,0.02756028,0.004300323],"category_scores_gemma":[0.03133217,0.0005533517,0.00124666,0.0008376258,0.002546225,0.005607898,0.001342989,0.02662632,0.003388719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0029678,"about_ca_system_score_gemma":0.003192592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002598192,"about_ca_topic_score_gemma":0.004722605,"domain_scores_codex":[0.9950635,0.002375822,0.000703688,0.0003415154,0.001113848,0.0004017194],"domain_scores_gemma":[0.978292,0.01428505,0.001044108,0.0004696244,0.003716405,0.002192822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002076496,0.00009550436,0.004081008,0.0003175784,0.00006811759,0.002254785,0.0001316898,0.0001672459,0.0003656416,0.004997737,0.920319,0.06699409],"study_design_scores_gemma":[0.0004123907,0.0002677564,0.004288853,0.002104879,0.0001960825,0.006058905,0.0008425644,0.00155569,0.0004233948,0.0387807,0.944918,0.000150732],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.0002947305,0.008861961,0.0001442871,0.9799326,0.009498461,0.000004713558,0.00003130625,0.0000158414,0.001216129],"genre_scores_gemma":[0.009126693,0.01474477,0.0009197817,0.834929,0.1373396,0.00003780117,0.0000871654,0.0000218915,0.002793179],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.02756028,"threshold_uncertainty_score":0.03487015,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02783545083460224,"score_gpt":0.2649945253372427,"score_spread":0.2371590745026404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}